EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

 26.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 31.85
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 449.09m
  • Volume: 59
  • Market Cap: £116.76m
  • Beta: 0.01

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 26.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 31.85
52 Week Low 18.75
Volume 59
Shares Issued 449.09m
Market Cap £116.76m
Beta 0.01

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.04% below the market average87.04% below the market average87.04% below the market average87.04% below the market average87.04% below the market average
82% below the sector average82% below the sector average82% below the sector average82% below the sector average82% below the sector average
Price Trend
40.88% below the market average40.88% below the market average40.88% below the market average40.88% below the market average40.88% below the market average
47.57% below the sector average47.57% below the sector average47.57% below the sector average47.57% below the sector average47.57% below the sector average
Income Not Available
Growth
59.24% above the market average59.24% above the market average59.24% above the market average59.24% above the market average59.24% above the market average
59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 04-Jul-2025

Time Volume / Share Price
08:34 40 @ 26.94p
08:00 19 @ 26.10p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page